Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma, a regulatory filing said.
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
Natco Pharma Ltd | United States | pharmaceutical firms
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma, a regulatory filing said.
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Natco Pharma Ltd on Friday said it has launched additional strengths for its generic lenalidomide capsules used in the treatment of multiple myeloma, in the US.
The company has launched 2.5 mg, and 20 mg strengths of the generic version of Revlimid (lenalidomide capsules) through its marketing partner Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd, Natco Pharma said in a regulatory filing.
"With this launch the companies (have) made available all the strengths of lenalidomide in the US market," it added.
Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma, the filing said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Fri, March 10 2023. 14:01 IST
In the competitive landscape of the US banking sector, retaining depositors is paramount for lenders seeking to maintain... Read more
In the realm of banking, the ability to predict and prevent failures is paramount for financial stability and consumer c... Read more
In the evolving landscape of global financial markets, the strategic role of central banks has come under intense scruti... Read more
Author: Ricardo Goulart ... Read more
Author: Gerardine Lucero  ... Read more
When it comes to banking, a significant new contender has entered the ring. The principles of Islamic banking and financ... Read more